Tuzulby: A New Chewable Option for ADHD Treatment

Tuzulby is an exciting development in ADHD care, offering a prolonged-release methylphenidate option in a chewable tablet form.

For many young people, swallowing tablets or capsules can be a real barrier to treatment. This can be especially challenging for children and teenagers who have sensory sensitivities, including those with co-occurring autism, or for those who dislike the taste or texture of capsule contents.

Tuzulby is cherry flavoured, which may make it easier and more acceptable for some young people to take. It also offers a practical alternative for families who have previously relied on methylphenidate liquid, which can be very expensive, particularly when prescribed privately.

Another helpful feature is that some strengths can be divided into equal doses, which may support more flexible titration and reduce waste during dose adjustments. This can make the process more economical for families while still allowing treatment to be tailored carefully.

For young people who struggle with standard tablets or capsules, Tuzulby may be a welcome and practical new option.